Cardiac Valvular Medicine

  • Nalini M. Rajamannan

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Helena J. Heuvelman, Nalini Marie Rajamannan, Johanna J. M. Takkenberg
    Pages 1-8
  3. Mony Shuvy, Chaim Lotan, Nalini Marie Rajamannan
    Pages 9-15
  4. Philippe Sucosky, Nalini Marie Rajamannan
    Pages 17-21
  5. Malayannan Subramaniam, Thomas C. Spelsberg, Nalini Marie Rajamannan
    Pages 23-33
  6. Anders M. Greve, Kristian Wachtell
    Pages 35-45
  7. Patrizio Lancellotti, Julien Magne
    Pages 47-57
  8. Antonia Delgado Montero, Alexandra Gonçalves, Nalini M. Rajamannan, José Luis Zamorano
    Pages 59-63
  9. Philippe Pibarot, Jean G. Dumesnil
    Pages 65-82
  10. M. Chrissoheris, K. Spargias
    Pages 83-91
  11. Alexandra Gonçalves, José Luis Zamorano
    Pages 93-102
  12. Margaret A. Lloyd, Charanjit S. Rihal
    Pages 103-110
  13. Francesco Antonini-Canterin, Luis Moura, Nalini Marie Rajamannan
    Pages 111-121
  14. Franck Thuny, Gilbert Habib
    Pages 147-155
  15. José Juan Gómez de Diego, Nalini Marie Rajamannan
    Pages 157-172
  16. Elena Aikawa, K. Jane Grande-Allen
    Pages 173-185
  17. M. J. Swaans, J. A. S. van der Heyden
    Pages 187-209
  18. Cristina Basso, Denisa Muraru, Luigi P. Badano, Gaetano Thiene
    Pages 211-221
  19. Luigi P. Badano, Denisa Muraru
    Pages 223-248
  20. Back Matter
    Pages 249-254

About this book


Experimental studies in the field of cardiac valve biology are now demonstrating that the cardiac valve disease process is an active biology with risk factors analogous to vascular risk factors.  Understanding the risk factors is also evolving rapidly, giving physicians and scientists insight into the cellular mechanisms and raising the possibility of treating these valve lesions with other options besides surgical valve repair. Our knowledge of right-sided valve lesions is also rapidly becoming important in the field of valvular medicine. Not only is the pathology different from left-sided valve lesions, but the hemodynamic compromise is more complex and difficult to treat in patients who develop tricuspid or pulmonic valve disease. Early diagnosis and careful management of this patient population is critical for long term outcomes in this patient population.


Cardiac Valvular Medicine represents an overview of the most recent science, clinical trials and new discoveries in the field of valvular heart disease. The editor has assembled a team of highly experienced contributors to provide a thorough translational understanding of the current and future treatments for this patient population. Cardiologists, internists, family practice physicians, cardiac surgeons and basic scientists will all find enormous benefit from this textbook.


Cardiac Surgery Cardiology Internal Medicine

Editors and affiliations

  • Nalini M. Rajamannan
    • 1
  1. 1., Molecular Biology and BiochemistryMayo ClinicRochesterUSA

Bibliographic information